Our four smoke-free platforms
Our platforms are at different stages of development and commercialization.
 |
 |
 |
 |
|
| Products | Platform 1 Heated Tobacco Product | Platform 2 Heated Tobacco Product | Platform 3 Nicotine-Containing E-Vapor | Platform 4 Nicotine Containing E-Vapor |
|---|---|---|---|---|
Technology |
Heated Tobacco Product Learn more about Platform1 Also referred to as EHTP or THS |
Heated Tobacco Product Learn more about Platform 2 Also referred to as CHTP |
E-Vapor Learn more about Platform 3 |
E-Vapor Learn more about Platform 4 |
Nicotine Source |
Tobacco | Tobacco | Nicotine salt | E-liquid |
Max Temperature |
below 350° C (cigarettes up to 900° C) |
below 350° C (cigarettes up to 900° C) |
100° C | 200-220° C |
Heat Source & Battery |
Electronically controlled ceramic heat-blade
Li-ion |
Charcoal
None |
Electronically controlled heater
Li-ion |
Electronically controlled MESH heater
Li-ion |
Our findings to date |
Average of 90-95% reduction of levels of HPHCs* Average of 90-95% reduction in toxicity* |
Average of 90-95% reduction of levels HPHCs* Average of 90-95% reduction in toxicity |
Ongoing | Ongoing |
| A reduction in biomarkers of exposure similar to levels found in smoking cessation.
Favorable changes in health indicators upon switching to Platform 1**. |
A reduction in biomarkers of exposure similar to levels found in smoking cessation.** | Planned for 2018 | ||
| Intent to use among non-smokers up to 6.4%, among adult smokers up to 39%
Post-market surveillance ongoing |
Perception and behavior study ongoing | Planned for 2018 | Planned for 2018 | |
commercialization |
Yes | Yes | No | Yes |
